Nystatin And Triamcinolone Acetonide
NDC 52565-042
Product Information
Nystatin And Triamcinolone Acetonide is a ANDA-approved product labeled by Teligent Pharma, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 52565-042 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 52565-042?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- NYSTATIN (UNII: BDF1O1C72E)
- NYSTATIN (UNII: BDF1O1C72E) (Active Moiety)
- TRIAMCINOLONE ACETONIDE (UNII: F446C597KA)
- TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MINERAL OIL (UNII: T5L8T28FGP)
- PETROLATUM (UNII: 4T6H12BN9U)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1053697 - nystatin 100,000 UNT/GM / triamcinolone acetonide 1 MG/GM Topical Ointment
- RxCUI: 1053697 - nystatin 100 UNT/MG / triamcinolone acetonide 0.001 MG/MG Topical Ointment
- RxCUI: 1053697 - nystatin 100,000 UNT/GM / triamcinolone acetonide 0.1 % Topical Ointment
* Please review the full disclaimer at the bottom of this page.
Patient Education
Nystatin and Triamcinolone
The combination of nystatin and triamcinolone is used to treat fungal skin infections. It relieves itching, inflammation, and pain. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the full disclaimer at the bottom of this page.